358 related articles for article (PubMed ID: 17712718)
21. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth.
McNeil CJ; Nwagwu MO; Finch AM; Page KR; Thain A; McArdle HJ; Ashworth CJ
Reproduction; 2007 Mar; 133(3):653-61. PubMed ID: 17379659
[TBL] [Abstract][Full Text] [Related]
23. The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non-pregnant bovine endometrium.
Lee HY; Acosta TJ; Tanikawa M; Sakumoto R; Komiyama J; Tasaki Y; Piskula M; Skarzynski DJ; Tetsuka M; Okuda K
J Endocrinol; 2007 Apr; 193(1):127-35. PubMed ID: 17400810
[TBL] [Abstract][Full Text] [Related]
24. Differential expression and activity of 11beta-hydroxysteroid dehydrogenase in human placenta and fetal membranes from pregnancies with intrauterine growth restriction.
Wächter R; Masarik L; Bürzle M; Mallik A; von Mandach U
Fetal Diagn Ther; 2009; 25(3):328-35. PubMed ID: 19776596
[TBL] [Abstract][Full Text] [Related]
25. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
Jang C; Obeyesekere VR; Dilley RJ; Alford FP; Inder WJ
Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
[TBL] [Abstract][Full Text] [Related]
26. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
27. Circulating 11beta-hydroxysteroid dehydrogenase type 1 mRNA and cardiovascular risk factors.
Al Bakir M; Butt AN; Swaminathan R
Ann N Y Acad Sci; 2008 Aug; 1137():283-9. PubMed ID: 18837961
[TBL] [Abstract][Full Text] [Related]
28. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
Draper N; Stewart PM
J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
[TBL] [Abstract][Full Text] [Related]
29. Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain.
Pelletier G; Luu-The V; Li S; Bujold G; Labrie F
Neuroscience; 2007 Mar; 145(1):110-5. PubMed ID: 17207581
[TBL] [Abstract][Full Text] [Related]
30. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
[TBL] [Abstract][Full Text] [Related]
31. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
[TBL] [Abstract][Full Text] [Related]
33. Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation.
Rabbitt EH; Lavery GG; Walker EA; Cooper MS; Stewart PM; Hewison M
FASEB J; 2002 Jan; 16(1):36-44. PubMed ID: 11772934
[TBL] [Abstract][Full Text] [Related]
34. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
[TBL] [Abstract][Full Text] [Related]
35. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
[TBL] [Abstract][Full Text] [Related]
36. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
Terao M; Itoi S; Murota H; Katayama I
Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S
J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581
[TBL] [Abstract][Full Text] [Related]
39. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ; Latif SA; Hardy MP; Brem AS
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
[TBL] [Abstract][Full Text] [Related]
40. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.
Schnackenberg CG
Curr Opin Investig Drugs; 2008 Mar; 9(3):295-300. PubMed ID: 18311666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]